ONEMEDNET Corp Sees 75% Stock Surge Amid New Partnerships

ONEMEDNET CORP: Delivering Regulatory-Grade Real-World Data

ONEMEDNET CORP (Nasdaq: ONMD) is a publicly traded company headquartered in Eden Prairie, Minnesota. The company operates the proprietary iRWD™ platform, which de-identifies and curates regulatory-grade Real-World Data (RWD) from over 1,400 healthcare providers. ONMD’s data offerings encompass electronic health records, clinical exams, laboratory results, and medical imaging, aimed at supporting drug development, medical device innovation, and AI-driven diagnostics. As of June 24, 2025, the share price was $0.5959, representing a 75.26% increase on a trading volume of 18,849,706 shares.

Corporate Structure and Leadership

Founded in 2006, ONEMEDNET employs between 11 and 50 professionals across data science, engineering, compliance, and customer support. The board of directors includes specialized committees in audit, compensation, and governance, with the following senior executives overseeing operations:

• Dr. Jeffrey Yu, Chairman and Chief Medical Officer, board-certified radiologist and founder of the BEAM imaging solution.
• Aaron Green, President and Chair of the Commercial Committee, responsible for partnership strategy and network expansion.
• Bob Golden, Chief Financial Officer, CPA with over 30 years of experience in accounting, tax planning, and financial consulting.
• Steven Chartier, Vice President of Engineering and Chief of Data, with expertise in unifying heterogeneous clinical data into scalable platforms.

Developments and News

• June 24, 2025: Filed an 8-K with the SEC reporting material agreements and announcing strategic collaborations, coinciding with the increase in share price.
• May 14, 2025: Submitted Form 10-Q for the quarter ended March 31, detailing operational milestones and subscription revenue streams.
• May 13, 2025: Expanded platform capabilities to integrate additional imaging sources, enhancing interoperability for life sciences research.
• April 29, 2025: Rolled out imaging source integrations aimed at broadening access to multimodal data for post-market surveillance.
• April 23, 2025: Partnered with Protege to facilitate real-time, multimodal patient data access for AI training workflows.
• March 10, 2025: Joined Datavant’s Real-World Data ecosystem, creating secure linkages across healthcare datasets.
• November 8, 2023: Completed a business combination with Data Knights Acquisition Corp., commencing trading on Nasdaq under the ticker ONMD.

Financial and Strategic Analysis

ONEMEDNET’s subscription-based revenue model provides continuous access to longitudinal data feeds, with expert curation services tailored to customer specifications. The company emphasizes data masking and human-in-the-loop validation to align with HIPAA and global privacy standards. The May 14, 2025, 10-Q indicated growth in subscription revenues, although detailed figures were not disclosed. Key strategic initiatives include:

• Scaling the iRWD™ network beyond 1,400 sites to capture broader patient cohorts.
• Enhancing AI-ready data pipelines to support expedited drug discovery and diagnostic algorithm training.
• Strengthening integrations with cloud-based platforms such as AWS Clean Rooms for secure, collaborative analytics.

Market Position and Industry Context

ONEMEDNET operates in the $400 billion clinical research and trial data market, where regulatory-grade RWD is critical for post-market surveillance, health outcomes research, and AI-driven medical innovation. Partnerships with Datavant and Protege reflect the company’s involvement in cross-ecosystem data connectivity. Unlike static RWD providers, ONMD’s real-time, prospective data access and comprehensive patient records provide a dataset that supports longitudinal studies over an extended period. This capability addresses the demand from biopharma, medical device manufacturers, and healthcare analytics firms for validated, de-identified data at scale.

tl;dr

On June 24, 2025, ONEMEDNET’s stock rose to $0.5959, marking a 75.26% increase following an SEC 8-K filing and announcements of new strategic agreements. Since March 2025, the company has partnered with Datavant and Protege, expanded imaging integrations, and submitted its Q1 2025 10-Q. Ongoing network growth, subscription revenue expansion, and AI-ready data services are expected to contribute to operational momentum through the second half of 2025.